CNW/ -- (CSE: BIOV) (FRA: 5LB) ("BioVaxys" or the "Company") is pleased to provide a summary of current operating ...

Professor Wei Shen Lim KBE will become the new Chair of the Joint Committee on Vaccination and Immunisation from October. Professor Sir Andrew ...

RSV seasons ended earlier than usual in 2022-23 and 2023-24, and typical human hMPV circulation patterns have returned since the COVID-19 pandemic.

Paradromics' Brain-Computer Interface has been tested briefly in a patient with epilepsy. Neuralink, Precision Neuroscience, and Synchron also have devices in the works. Other news looks at a ...

The biotech’s mRNA vaccines were lauded by the first Trump administration but now are caught up in government changes to ...

Cuts in NIH grants and the threat of more are discouraging investment and may drive trials out of the United States.

The study authors say flu or RSV may increase the risk of S pneumoniae infection by damaging the bronchi and lung epithelium, ...

A Phase III trial demonstrated mNEXSPIKE’s non-inferior efficacy compared with Moderna’s original COVID vaccine, Spikevax.

The results of the non–peer-reviewed research highlight the risk of contracting H5N1 avian flu from consuming unpasteurized ...

Aeroplane air health primarily concerns the quality, safety, and potential health impacts of the air that passengers and crew breathe during flights. This ...

The current uptick in COVID-19 in Asia and India seems to follow an emerging seasonal pattern of SARS-CoV-2’ | Photo Credit: ...

Moderna's mNexspike COVID vaccine approved by FDA for older adults and at-risk groups after Phase 3 trial shows improved ...